More on SGMT

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (9.4 Score)

Upcoming Events

- Earnings (11/12/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Sagimet Biosciences (NQ:SGMT)
Delayed: 9.58 -0.37 (3.72%)
Prev. Close $9.95  
Open$9.95 
52 Wk High$ 
52 Wk Low$ 
Day High$9.95 
Day Low$9.50 
P/E N/A  
EPS$ 
Volume694,947 

Friends, Peers and Foes (?): OMER (more...)

Oct 22, 2026 07:15 AM Form 8-K Sagimet Biosciences Inc. For: Oct 22
Oct 22, 2026 07:00 AM Sagimet doses first patient in Phase 3 acne trial for denifanstat
Oct 22, 2026 07:00 AM Sagimet Biosciences Announces First Patient Dosed in AURORA Phase 3 U.S. Clinical Trial of Denifanstat for Moderate to Severe Acne
Oct 9, 2026 07:00 AM Sagimet to present 52-week denifanstat acne trial data at Las Vegas conference
Oct 9, 2026 07:00 AM Sagimet to present 52-week denifanstat acne trial data at Las Vegas conference
Oct 9, 2026 07:00 AM Sagimet To Present Positive Full 52-Week Results from License Partner Ascletis' Phase 3 Open-Label Extension Clinical Trial of Denifanstat in Acne and Mechanistic Data at the 2026 Fall Clinical D
Oct 9, 2026 07:00 AM Sagimet To Present Positive Full 52-Week Results from License Partner Ascletis' Phase 3 Open-Label Extension Clinical Trial of Denifanstat in Acne and Mechanistic Data at the 2026 Fall Clinical Dermat
Oct 7, 2026 06:28 PM Form SCHEDULE 13G Sagimet Biosciences Inc. Filed by: Commodore Capital LP
Oct 2, 2026 06:46 AM Sagimet Biosciences Inc (SGMT) PT Raised to $26 at Guggenheim
Oct 1, 2026 04:31 PM Sagimet Biosciences closes $115M stock and warrant offering
View All Articles

Entities mentioned with SGMT

View All Entities